Abstract 2141: Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI.

Abstract Gliomas are the most common type of primary brain tumors. Innovative therapies are vital to improve treatment outcomes but to be efficient, trafficking across the blood brain barrier (BBB) is required. For this advent, animal models provide important information prior to clinical studies. Among the different in vivo models, orthotopic models mimic the biological environment. In addition to traditional mouse models, novel immunocompromised rat models offer new approach to preclinical efficacy testing facilitating PK/PD studies for IND enabling studies. SRG rats enable high engraftment rates and rapid growth of a variety of human tissues and tumors. Severe immunodeficiency ensures high engraftment rates and larger organism size allows larger sample collection e.g. for blood biomarker analysis. Especially in the brain tumor research, imaging has a central role in clinical diagnosis and as a prognostic factor to monitor therapy response. It enables longitudinal monitoring in a fully translational manner. Magnetic resonance imaging (MRI) offers unprecedented soft tissue contrast, high spatial resolution and non-invasive nature renders MRI in rodents a perfect tool for preclinical work in oncological applications. In addition to monitor tumor growth, cerebral blood flow (CBF) and leakage of BBB can be measured with a contrast agent. Perfusion indicates angiogenesis in tumor, one hallmark of most malignant gliomas as well the leakage status of glioma is critical to understand for possible therapeutic intervention. The purpose of this work was to establish orthotopic glioma model in SRG rats using U87MG cells. Development of brain pathologies were longitudinally monitored in vivo using MRI. Key readouts were anatomical visualization of abnormalities, tumor volumetry, vascularization in tumor, CBF and development of BBB leakage. Differences in CBF represents mass effect from brain tumors impairing blood flow in the surrounding brain parenchyma. As a conclusion, translational in vivo imaging techniques were applied to study orthotopic tumor progression. These readouts provide a powerful and translational research tool together with oncological disease animal models with detailed understanding about disease progression and improved treatment intervention design. Citation Format: Tuulia Huhtala, Jussi Rytkönen, Riikka Immonen, Ayhan Korkmaz, Torsten Giesemann, Julia B. Schueler. Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2141.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-2141
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2141: Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI.

Riikka Immonen, Tuulia Huhtala, Torsten Giesemann, Jussi Rytkönen et al.
Cancer Research
Cancer Research and Treatments
article

Abstract 2141: Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI.

Riikka Immonen, Tuulia Huhtala, Torsten Giesemann, Jussi Rytkönen, Ayhan Korkmaz, Julia B. Schueler
article en

Abstract

Abstract Gliomas are the most common type of primary brain tumors. Innovative therapies are vital to improve treatment outcomes but to be efficient, trafficking across the blood brain barrier (BBB) is required. For this advent, animal models provide important information prior to clinical studies. Among the different in vivo models, orthotopic models mimic the biological environment. In addition to traditional mouse models, novel immunocompromised rat models offer new approach to preclinical efficacy testing facilitating PK/PD studies for IND enabling studies. SRG rats enable high engraftment rates and rapid growth of a variety of human tissues and tumors. Severe immunodeficiency ensures high engraftment rates and larger organism size allows larger sample collection e.g. for blood biomarker analysis. Especially in the brain tumor research, imaging has a central role in clinical diagnosis and as a prognostic factor to monitor therapy response. It enables longitudinal monitoring in a fully translational manner. Magnetic resonance imaging (MRI) offers unprecedented soft tissue contrast, high spatial resolution and non-invasive nature renders MRI in rodents a perfect tool for preclinical work in oncological applications. In addition to monitor tumor growth, cerebral blood flow (CBF) and leakage of BBB can be measured with a contrast agent. Perfusion indicates angiogenesis in tumor, one hallmark of most malignant gliomas as well the leakage status of glioma is critical to understand for possible therapeutic intervention. The purpose of this work was to establish orthotopic glioma model in SRG rats using U87MG cells. Development of brain pathologies were longitudinally monitored in vivo using MRI. Key readouts were anatomical visualization of abnormalities, tumor volumetry, vascularization in tumor, CBF and development of BBB leakage. Differences in CBF represents mass effect from brain tumors impairing blood flow in the surrounding brain parenchyma. As a conclusion, translational in vivo imaging techniques were applied to study orthotopic tumor progression. These readouts provide a powerful and translational research tool together with oncological disease animal models with detailed understanding about disease progression and improved treatment intervention design. Citation Format: Tuulia Huhtala, Jussi Rytkönen, Riikka Immonen, Ayhan Korkmaz, Torsten Giesemann, Julia B. Schueler. Progression of blood brain barrier leakage in orthotopic glioma SRG rat model using contrast enhanced MRI [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2141.

Cancer ResearchVol. 86(7_Supplement)
Charles River Laboratories (Netherlands) (NL), Charles River Laboratories (United States) (US)
Openalex Percentile: Top 6%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.